| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |